Pathophysiology of atherosclerosis: Association of risk factors and treatment strategies using plant‐based bioactive compounds
- 27 August 2020
- journal article
- review article
- Published by Wiley in Journal of Food Biochemistry
- Vol. 44 (11) , e13449
Abstract
Under physiological conditions, endothelial cells act as protective barrier which prevents direct contact of blood with circulating factors via production of tissue plasminogen activator. Risk factors of metabolic disorders are responsible to induce endothelial dysfunction and may consequently lead to prognosis of atherosclerosis. This article summarizes the process of atherosclerosis which involves number of sequences including formation and interaction of AGE‐RAGE, activation of polyol pathway, protein kinase C, and hexosamine‐mediated pathway. All these mechanisms can lead to the development of oxidative stress which may further aggravate condition. Different pharmacological interventions are being used to treat atherosclerosis, however, these might be associated with mild to severe side effects. Therefore, plant‐based bioactive compounds having potential to combat and prevent atherosclerosis in diabetic patients are attaining recent focus. By understanding process of development and mechanisms involved in atherosclerotic plaque formation, these bioactive compounds can be better option for future therapeutic interventions for atherosclerosis treatment. Practical applications Atherosclerosis is one of major underlying disorders of cardiovascular diseases which occur through multiple mechanisms and is associated with metabolic disorders. Conventional therapeutic interventions are not only used to treat atherosclerosis, but are also commonly associated with mild to severe side effects. Therefore, nowadays, bioactive compounds having potential to combat and prevent atherosclerosis in diabetic patients are preferred. By understanding mechanisms involved in atherosclerotic plaque formation, bioactive compounds can be better understood for treatment of atherosclerosis. In this manuscript, we have focused on treatment strategies of atherosclerosis using bioactive compounds notably alkaloids and flavonoids having diverse pharmacological and therapeutic potentials with special focus on the mechanism of action of these bioactive compounds suitable for treatment of atherosclerosis. This manuscript will provide the scientific insights of bioactive compounds to researchers who are working in the area of drug discovery and development to control pathogenesis and development of atherosclerosis and its associated cardiometabolic disorders.Keywords
Funding Information
- Higher Education Commision, Pakistan (5661/Punjab/NRPU/R&D/HEC/2016, 6429/Punjab/NRPU/R&D/HEC/2016, 8365/Punjab/NRPU/R&D/HEC/2017)
This publication has 228 references indexed in Scilit:
- The effects of plant stanol ester consumption on arterial stiffness and endothelial function in adults: a randomised controlled clinical trialBMC Cardiovascular Disorders, 2013
- The cholesterol lowering efficacy of plant stanol ester yoghurt in a Turkish population: a double-blind, placebo-controlled trialLipids in Health and Disease, 2013
- Serum Carotenoids Reduce Progression of Early Atherosclerosis in the Carotid Artery Wall among Eastern Finnish MenPLOS ONE, 2013
- The Vascular Endothelium and Human DiseasesInternational Journal of Biological Sciences, 2013
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011
- Lipids and Lipoproteins in AtherosclerosisJournal of Lipids, 2011
- Inhibition of Ca 2+ ‐activated Cl − channels by gallotannins as a possible molecular basis for health benefits of red wine and green teaThe FASEB Journal, 2010
- Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009Diabetologia, 2010
- The effect of a very high daily plant stanol ester intake on serum lipids, carotenoids, and fat-soluble vitaminsClinical Nutrition, 2010
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993